Gene and cell therapy is emerging as a new and promising field to treat, and in some cases, cure diseases that previously had few treatment options. Today, there are over 400 gene and cell therapy candidates in the U.S. drug pipeline. While the industry offers hope to those with a disease that could potentially be addressed by a gene or cell therapy, it still faces many challenges in developing these cutting-edge products and bringing them to market. Some of the largest barriers to these treatments are pricing, reimbursement and manufacturing. We will take a look at how insurance plans can address the high costs of these treatments while ensuring that their patients have access to therapy, and how specialty pharmacies can play an integral role in the distribution model.
Topics to Be Reviewed
Gene and cell therapy are shifting paradigms for manufacturers, patients, healthcare providers and pharmacies. These technologies offer hope and promise to millions of patients for the future. We invite you to learn more by reading Gene and Cell Therapy: A New Age of Medicine.
Offered Free by: AllianceRx Walgreens Prime
See All Resources from: AllianceRx Walgreens Prime